A Nanoparticle Platform for Improved Potency, Stability, and Adjuvanticity of Poly(I:C)
暂无分享,去创建一个
Eric A. Appel | Anton A. A. Smith | Gillie A. Roth | Emily C. Gale | M. Alcántara-Hernández | J. Idoyaga
[1] M. Markowitz,et al. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial , 2019, Front. Immunol..
[2] Yang Yang,et al. Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity. , 2018, ACS nano.
[3] G. Smyth,et al. SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition. , 2017, Immunity.
[4] M. Diallo,et al. Global Routine Vaccination Coverage, 2015. , 2016, MMWR. Morbidity and mortality weekly report.
[5] Özlem Türeci,et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.
[6] K. Ishii,et al. Vaccine adjuvants as potential cancer immunotherapeutics , 2016, International immunology.
[7] J. S. Suk,et al. Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain. , 2016, Small.
[8] L. Zitvogel,et al. Type I interferons in anticancer immunity , 2015, Nature Reviews Immunology.
[9] H. Merkle,et al. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. , 2013, Advanced drug delivery reviews.
[10] Jordan J. Green,et al. A bioreducible linear poly(β-amino ester) for siRNA delivery. , 2013, Chemical communications.
[11] R. Steinman,et al. Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells. , 2013, Nature chemical biology.
[12] John Steel,et al. Programming the magnitude and persistence of antibody responses with innate immunity , 2010, Nature.
[13] T. Batchelor,et al. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. , 2010, Neuro-oncology.
[14] S. Boppart,et al. Lymphatic Biodistribution of Polylactide Nanoparticles , 2010, Molecular imaging.
[15] M. Tirrell,et al. Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists , 2010, Expert review of vaccines.
[16] R. Steinman,et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant , 2009, The Journal of experimental medicine.
[17] Richard A Flavell,et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[18] Rolf M. Zinkernagel,et al. Antiviral antibody responses: the two extremes of a wide spectrum , 2006, Nature Reviews Immunology.
[19] Daniel G. Anderson,et al. Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.